Overview of the problem of infections in the immunocompromised host.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000008:administration & dosage; D004338:Drug Combinations; D006801:Humans; D007108:Immune Tolerance; D007239:Infections / Q000188:drug therapy / Q000209:etiology*; D009503:Neutropenia / Q000150:complications; D013982:Ticarcillin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004338:Drug Combinations; D019818:Clavulanic Acid; D013982:Ticarcillin